FAVALLI, CARTESIO
 Distribuzione geografica
Continente #
NA - Nord America 47.213
EU - Europa 3.612
AS - Asia 1.058
SA - Sud America 21
Continente sconosciuto - Info sul continente non disponibili 14
AF - Africa 5
OC - Oceania 4
Totale 51.927
Nazione #
US - Stati Uniti d'America 47.191
CN - Cina 772
UA - Ucraina 734
DE - Germania 683
IT - Italia 383
IE - Irlanda 380
FR - Francia 359
SE - Svezia 341
GB - Regno Unito 228
KR - Corea 155
PL - Polonia 149
FI - Finlandia 145
RU - Federazione Russa 111
BE - Belgio 52
JP - Giappone 34
VN - Vietnam 20
IN - India 18
UZ - Uzbekistan 15
EU - Europa 13
CA - Canada 12
NL - Olanda 12
BR - Brasile 10
IL - Israele 10
IR - Iran 10
RO - Romania 9
HK - Hong Kong 7
DM - Dominica 6
SG - Singapore 6
CH - Svizzera 5
ES - Italia 5
AR - Argentina 4
AU - Australia 4
CL - Cile 4
CZ - Repubblica Ceca 3
MX - Messico 3
TH - Thailandia 3
AT - Austria 2
BG - Bulgaria 2
EG - Egitto 2
GR - Grecia 2
KG - Kirghizistan 2
MD - Moldavia 2
ME - Montenegro 2
PK - Pakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
BO - Bolivia 1
CO - Colombia 1
DZ - Algeria 1
EC - Ecuador 1
MY - Malesia 1
PA - Panama 1
PH - Filippine 1
SA - Arabia Saudita 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 51.927
Città #
Woodbridge 15.783
Wilmington 12.822
Houston 11.384
Ann Arbor 1.379
Fairfield 889
Chandler 820
Jacksonville 682
Ashburn 395
Dublin 380
Seattle 377
Dearborn 358
Medford 302
Cambridge 289
Zhengzhou 276
Beijing 214
Kraków 149
Lawrence 145
Mülheim 128
New York 108
Rome 104
Menlo Park 71
Shanghai 70
Boardman 65
Milan 61
San Diego 54
Brussels 52
University Park 48
Palo Alto 40
San Mateo 37
Hefei 36
Mountain View 31
Redwood City 24
Kunming 22
Falls Church 21
Norwalk 19
Verona 19
Detroit 18
London 17
Nürnberg 17
Saint Petersburg 16
Hangzhou 14
Nanjing 14
Guangzhou 13
Chicago 12
Hanoi 12
Los Angeles 12
Auburn Hills 10
Jinan 10
Toronto 10
Chongqing 9
Belfast 8
Fuzhou 8
Dong Ket 7
Nanchang 7
Chiswick 6
Haikou 6
Roseau 6
Tappahannock 6
Tokyo 6
Baotou 5
Hebei 5
Indiana 5
Mcallen 5
Phoenix 5
San Francisco 5
Simi Valley 5
Torino 5
Buenos Aires 4
Chengdu 4
Helsinki 4
Hong Kong 4
Hounslow 4
Redmond 4
Shenyang 4
Brno 3
Changsha 3
Clearwater 3
Genova 3
Groningen 3
Jinhua 3
Kilburn 3
Moscow 3
Portici 3
Quzhou 3
Scafati 3
Shenzhen 3
Stockholm 3
Wuhan 3
Xian 3
Ypsilanti 3
Alessano 2
Bangkok 2
Berane 2
Bhandup 2
Bologna 2
Bucharest 2
Caccamo 2
Capannelle 2
Chisinau 2
Choppington 2
Totale 48.034
Nome #
Acinetobacter baumannii in intensive care unit: A novel system to study clonal relationship among the isolates 498
Combination treatment with zidovudine, thymosin alpha 1 and interferon-alpha in human immunodeficiency virus infection. 480
Black Stain: studio clinico e microbiologico 476
Historical review on thymosin α1 in oncology: preclinical and clinical experiences 471
Thymosin alpha 1: From bench to bedside 470
Changes in apoptosis after interruption of potent antiretroviral therapy in patients with maximal HIV-1-RNA suppression 462
Detection of clarithromycin-resistant Helicobacter pylori in stool samples 447
p16INK4A expression is related to grade of CIN and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome 438
Isolation and characterization of a DNA probe for Staphylococcus aureus subspecies aureus biovar 436
Upregulation of telomerase (hTERT) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus, virus persistence, or disease outcome in cervical cancer 434
INHIBITION OF RAT FIBROBLAST CELL-PROLIFERATION AT SPECIFIC CELL-CYCLE STAGES BY COCAINE 433
Spontaneous and anti-Fas-induced apoptosis in lymphocytes from HIV-infected patients undergoing highly active anti-retroviral therapy 427
Emergence of KPC-producing Klebsiella pneumoniae in Italy 427
Umbilical cord blood: the role of apoptosis in the control of CD34+ cell counts 421
Susceptibility to influenza A virus infection in mice immunosuppressed with cyclophosphamide 421
Thymosin alpha 1: from bench to bedside 418
Thymic hormones and cytokines 416
Combination low-dose lymphoblastoid interferon and thymosin alpha(1) therapy in the treatment of chronic hepatitis B 415
Improved diagnosis of central venous catheter-related bloodstream infections using the HB&L UROQUATTRO™ system 415
Interleukin 4 stimulates infection and temporary growth of human neonatal lymphocytes exposed in vitro to human T-lymphotropic virus type I, but fails to substitute for interleukin 2 in the immortalization of infected cultures 413
AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro 412
Leucocyte rheological properties are altered in patients with diffuse atherosclerosis 412
Influence of cocaine on murine immune surveillance. 409
Interleukin 4 stimulates infection and temporary growth of human neonatal lymphocytes exposed in vitro to human T-lymphotropic virus type I, but fails to substitute for interleukin 2 in the immortalization of infected cultures 408
Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancer 407
Duodenal colonization by H. pylori is strongly associated with subsequent development of duodenal ulcer in patients with nonulcer dyspepsia 404
Umbilical cord blood: The role of apoptosis in the control of CD34+ cell counts 403
Inverse correlation between CD8+ lymphocyte apoptosis and CD4+ cell counts during potent antiretroviral therapy in HIV patients 401
Tazarotene as alternative topical treatment for onychomycosis 401
In vitro phencyclidine-induced inhibition of lymphocyte proliferation: prevention by cell activation 400
Effect of acute or daily cocaine administration on cellular immune response and virus infection in mice 397
Correlation between induction of lymphocyte apoptosis and prostaglandin E2 production by macrophages infected with HIV 397
THYMOSIN-ALPHA-1 POTENTIATES INTERLEUKIN 2-INDUCED CYTOTOXIC ACTIVITY IN MICE 396
Performance of strand displacement amplification assay in the detection of Chlamydia trachomatis and Neisseria gonorrhoeae 395
Entire genome of a strain of human immunodeficiency virus type 1 with a deletion of nef that was recovered 20 years after primary infection: Large pool of proviruses with deletions of env 395
Non ulcer dyspepsia is associated with helicobacter pylori infection in patients with Parkinson's disease 391
Immunological and endocrinological disturbances in patients after prolonged coma following head injury 390
Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study 390
Comparison of an enzyme immunoassay versus a rapid latex test for serodiagnosis of Helicobacter pylori infection 387
Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study 386
Combined treatment with thymosin alpha 1 and interferon enhances NK activity in immunosuppressed tumor bearing mice 385
Microbiologia ed immunologia del cavo orale 385
Use of the MicroSeq 500 16S rRNA gene-based sequencing for identification of bacterial isolates that commercial automated systems failed to identify correctly 383
Effect of thymosin alpha 1 on cocaine-induced inhibition of T cell dependent murine immune response. 383
Modulatory role of PGE2 on IL-2 production after in vivo treatment. 382
A multi-target real-time PCR assay for rapid identification of meningitis-associated microorganisms 382
Effect of PGE2 on c-Myc and Bcl-2 production and programmed cell death in human lymphocytes 381
Diagnosi di H pylori: fattori interferenti 380
Molecular mechanisms of Helicobacter pylori resistance to metronidazole 378
Effetto inibitorio della morfina sulla risposta immune: ruolo nella patogenesi delle infezioni virali. vol. 3, p. 1-16 378
CD4+ lymphocyte increases in HIV patients during potent antiretroviral therapy are dependent on inhibition of CD8+ cell apoptosis 376
Comparison of the eSwab collection and trasportation system to an amies gel transystem for Gram stain of clinical specimens 375
Evidence for antiviral activity of glutathione: In vitro inhibition of herpes simplex virus type 1 replication 374
Induction of apoptosis in thymocytes by prostaglandin E2 in vivo 374
Effect of di-M-PGE2 on T cell differentiation. Flow cytometry study at thymus level 373
Apoptotic cell signaling in lymphocytes from HIV+ patients during successful therapy 373
In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction 373
Synergistic effect of thymosin alpha 1 and alpha beta-interferon on NK activity in tumor-bearing mice 373
Studies on the induction of human lymphocyte apoptosis by prostaglandin-E2 372
Effect of PGE2 on c-Myc and Bcl-2 production and programmed cell death in human lymphocytes. 372
Single or multiple HPV types in cervical cancer and associated metastases 371
Combination low-dose lymphoblastoid interferon and thymosin α1 therapy in the treatment of chronic hepatitis B 370
Cocaine effects on cell-cycle progression. 368
Correlation between the effects of prostaglandins and interferon on B-16 melanoma growth and their modulation on natural killer activity 367
Combination therapy with BRMs in cancer and infectious diseases 367
Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer 367
Evaluation of BiesseBioscreen as a new methodology for bacteriuria screening 367
The combined use of VIGl@ct (R) (bioMerieux) and fluorescent amplified length fragment polymorphisms in the investigation of potential outbreaks 366
Infection with Helicobacter pylori and leukocyte response in patients with myocardial infarction 366
INHIBITORY EFFECT OF MORPHINE ON THE CONTROL OF RAT FIBROBLAST CELL-PROLIFERATION 365
Flow cytometric method for the evaluation of the biological activity of thymic hormones 365
Modifications in spleen lymphocyte subsets after cyclophosphamide and 16,16-dimethyl prostaglandin E2 administration in mice 365
Thymosin-alpha 1 regulates MHC class I expression in FRTL-5 cells at transcriptional level 364
Proteomic Investigation in A549 Lung Cell Line Stably Infected by HPV16E6/E7 Oncogenes. 364
Relationship of up-regulation of 67-kd laminin receptor to grade of cervical intraepithelial neoplasia and to high-risk HPV types and prognosis in cervical cancer 362
THYMOSIN ALPHA-1 RESTORES MURINE T-CELL-MEDIATED RESPONSES INHIBITED BY INVIVO COCAINE ADMINISTRATION 361
Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-alpha 1 and interferon-alpha 2a 361
Thymosin alpha 1 potentiates interleukin 2-induced cytotoxic activity in mice 361
Human papillomavirus (HPV) testing in the management of women with abnormal pap smears. Experience of a colposcopy referral clinic 359
Detection of oncogenic viruses (SV40, BKV, JCV, HCMV, HPV) and p53 codon 72 polymorphism in lung carcinoma 357
Co-expression of HSV2 and Chlamydia trachomatis in HPV-positive cervical cancer and cervical intraepithelial neoplasia lesions is associated with aberrations in key intracellular pathways 357
Upregulation of nuclear factor-kappaB (NF-kappaB) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus or disease outcome in cervical cancer 357
H. pylori eradication improves L-dopa absorption in patients with Parkinson’s disease 355
Efficacy of the combined treatment with fluconazole and thymosin alpha 1 against C. Albicans infection in morphine-treated mice. 354
Recombinant interferon alpha 2a, thymopentin and low doses of cytosine arabinoside for the treatment of myelodysplastic syndromes: a pilot study 352
Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer 350
New molecular mechanisms of resistance of Helicobacter pylori to clarithromycin 349
Combination therapy with thymosin alpha 1 potentiates the anti-tumor activity of interleukin-2 with cyclophosphamide in the treatment of the Lewis lung carcinoma in mice 346
combination treatment using thymosin alpha-1 and interferon after cyclophosphamide is able to cure lewis lung-carcinoma in mice 345
SEQUENTIAL EVALUATION OF GASTRIC INTRALUMINAL PROSTAGLANDIN-E2 RELEASE, ACID-SECRETION AND DNA-FLOW CYTOMETRY IN N-METHYL-N-NITRO-N-NITROSOGUANIDINE GASTRIC CARCINOGENESIS IN THE RAT 345
Interaction between thymic hormones and other immunomodulatory agents 345
Immunological events during the early phase of infection with Schistosoma mansoni in mice 344
Simple enzymatic method for rapid identification of a Staphylococcus aureus subspecies aureus biovar 341
A novel culturing system for fluid samples 340
C-reactive protein is increased in patients with degenerative aortic valvular stenosis 340
Comparison of DNA sequencing and Roche Linear array (R) in human papillomavirus (HPV) genotyping 339
Apoptosis-associated gene expression in HIV-infected patients in response to successful antiretroviral therapy 338
Effects of PGE2 on c-Myc and Bcl-2 protein expression and its relevance to programmed cell death in immature and mature human lymphocytes . 337
Effects of in vivo administration of di-M-PGE2 on spleen and thymus lymphocyte subsets in mice. 337
Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer 336
Totale 38.551
Categoria #
all - tutte 80.477
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.477


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193.828 0 0 0 0 0 0 0 0 0 1.246 1.370 1.212
2019/202013.746 1.343 1.175 1.030 1.306 1.116 1.435 1.269 1.211 1.108 1.034 742 977
2020/20217.489 852 922 817 936 760 768 942 808 203 95 296 90
2021/20221.454 38 162 70 118 56 162 44 97 84 132 55 436
2022/20232.111 177 163 33 341 234 448 144 110 174 7 200 80
2023/2024387 94 22 34 9 69 122 8 17 8 4 0 0
Totale 52.052